Nitrogen containing heteroaromatics as factor Xa inhibitors
申请人:DuPont Pharmaceuticals Company
公开号:US06020357A1
公开(公告)日:2000-02-01
The present application describes nitrogen containing heteroaromatics and derivatives thereof of formula I: ##STR1## or pharmaceutically acceptable salt or prodrug forms thereof, wherein J is N or NH and D may be C(.dbd.NH)NH.sub.2, which are useful as inhibitors of factor Xa.
[EN] NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS<br/>[FR] COMPOSES HETEROAROMATIQUES CONTENANT DE L'AZOTE, UTILISES EN TANT QU'INHIBITEURS DU FACTEUR Xa
申请人:DU PONT PHARMACEUTICALS COMPANY
公开号:WO1998028269A1
公开(公告)日:1998-07-02
(EN) The present application describes nitrogen containing heteroaromatics and derivatives thereof of formula (I) or pharmaceutically acceptable salt or prodrug forms thereof, wherein J is N or NH and D may be C(=NH)NH2, which are useful as inhibitors of factor Xa.(FR) La présente invention se rapporte à des composés hétéroaromatiques contenant de l'azote et à des dérivés de tels composés représentés par la formule (I), ou à des sels ou bioprécurseurs pharmaceutiquement acceptables de ces composés utiles en tant qu'inhibiteurs du facteur Xa. Dans la formule (I), J est N ou NH et D peut être C(=NH)NH2.
The invention is concerned with novel heteroarylacetamides of formula (I)
R
d
—C(O)—N(R
e
)—R
c
—CH
2
—C(O)—N(R
a
)(R
b
) (I)
wherein R
a
to R
e
are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.
The invention is concerned with novel heteroarylacetamides of formula (I)
R—C(O)—N(R
e
)—R
c
—CH
2
—C(O)—N(R
a
)(R
b
) (I)
wherein R
a
to R
e
are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.